
Work Here?
Ellipsis Health uses AI to screen and monitor behavioral health conditions such as depression and anxiety from a person’s voice for healthcare providers. It analyzes speech to identify vocal biomarkers that correlate with mental health status, delivering objective measures remotely and integrating into clinicians’ workflows. Its approach centers on automated vocal biomarkers within provider systems, enabling ongoing monitoring rather than stand-alone consumer tools. The goal is to improve patient outcomes and lower costs by making scalable, accessible mental health assessment available, including to underserved populations.
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$85.1M
Headquarters
San Francisco, California
Founded
2017
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$85.1M
Above
Industry Average
Funded Over
6 Rounds
Industry standards
Health Insurance
Vision Insurance
Dental Insurance
401(k) Company Match
Remote Work Options
Ellipsis Health, an AI healthcare company, has appointed Daniel Bensimhon, MD, as Chief Clinical Officer. Dr Bensimhon will lead clinical strategy as the company expands its AI Care Manager into complex cardiac conditions. Dr Bensimhon is a Duke-trained cardiologist with over 20 years of experience in heart failure care. He currently leads the Advanced Heart Failure and Mechanical Circulatory Support Program in Greensboro, North Carolina, and founded Ventricle Health, a value-based cardiac care platform. Ellipsis Health has developed Sage, an AI care manager built on eight years of clinical science and over 3 million clinical conversations. The company plans to expand beyond cardiovascular care into oncology, maternity, and behavioural health.
Ellipsis Health has partnered with Clearstep to integrate clinical triage capabilities into Sage, its AI Care Manager. The integration combines Ellipsis Health's Empathy Engine, which analyses vocal cues from over three million clinical conversations, with Clearstep's AI-powered triage protocols trusted by more than 300 hospitals. Sage can now conduct empathetic voice-based patient check-ins whilst seamlessly transitioning into structured symptom assessment and care navigation workflows. The partnership aims to help healthcare organisations provide round-the-clock care management, reducing missed escalations and unnecessary emergency room visits. Clearstep's triage protocols have served nearly seven million patients. The integration enables Sage to handle interactions ranging from routine wellness outreach to real-time symptom assessment, guiding patients to appropriate care levels.
HealthEdge has partnered with Ellipsis Health to integrate AI-powered virtual nursing into its Care Solutions suite. The collaboration brings Ellipsis Health's AI care management voice agent, Sage, to health plans seeking to scale member outreach whilst addressing clinical workforce shortages. Sage conducts autonomous phone conversations with members for high-volume outreach tasks including health risk assessments, post-discharge follow-ups, risk profiling and care gap closure. The system integrates with HealthEdge's GuidingCare platform, drawing on member data to personalise conversations and feeding outcomes back into the platform. Powered by Ellipsis Health's patented Empathy Engine, Sage analyses vocal cues in real time to assess emotional signals and adapt responses. The technology allows health plans to automate routine outreach, enabling nursing teams to focus on complex, high-touch interventions requiring clinical expertise.
Viz.ai, Alnylam Pharmaceuticals partner for cardiac amyloidosis detection and more digital health news. Ellipsis Health partners with PromptWell to boost enrollment in patient care programs, while CaryHealth teams up with HealthDyne to enhance medication management. Editor's note: This article has been updated to clarify Ellipsis Health's offerings. AI-backed imaging and care coordination company Viz.ai is partnering with RNAi therapeutics company Alnylam Pharmaceuticals to assist with the early identification and evaluation of patients with cardiac amyloidosis. Cardiac amyloidosis is a serious heart condition where misfolded amyloid proteins deposit in heart tissue, causing thickening of the muscle and stiffening, arrhythmias and heart failure. Viz.ai offers a disease detection and care coordination platform with more than 50 FDA-cleared algorithms that can help analyze medical imaging data to assist with diagnosis and treatment decisions. The company also offers AI-enabled tools for neurology, trauma, cardiology, radiology and vascular care. Through the partnership, Viz.ai will develop a cardiac amyloidosis-focused AI Care Pathway using its FDA-cleared echocardiography algorithm, Us2.ai, to identify patients with suggestive symptoms, coordinate testing to confirm the diagnosis, and follow up with cardiology and heart failure teams. "Cardiac amyloidosis is a condition where delayed diagnosis has real consequences in heart failure - earlier identification can fundamentally alter a patient's trajectory," Dr. Tim Showalter, CMO of Viz.ai, said in a statement. "This partnership is about making early detection actionable. By combining advanced imaging and generative AI with a care coordination platform, we will help clinicians find the right patients earlier and move them swiftly toward appropriate care before the window for meaningful intervention narrows." Ellipsis Health, a company that uses AI voice agent technology, is partnering with the patient engagement platform PromptWell with the aim of increasing enrollment in patient care programs. California-based Ellipsis offers an emotionally intelligent AI care management platform. The company works with healthcare organizations to help expand care capacity and improve patient engagement. PromptWell will integrate Ellipsis' AI care management voice tool, Sage, into its engagement platform with the goal of helping providers and payers improve connections with patients. "By integrating Sage's emotionally intelligent voice agent into our high-velocity engagement engine, we're creating a seamless path from outreach to action. Every touchpoint becomes more than just a notification, it becomes a clinically meaningful interaction that drives measurable ROI and better health outcomes," Kaushik Viswanathan, CEO of PromptWell, said in a statement. CaryHealth, which blends pharmacy services with tech-enabled tools, announced it is partnering with digital pharmacy and medication distribution company HealthDyne to combine digital patient engagement with a pharmacy infrastructure. HealthDyne offers medication services, including mail-order, central fill and specialty pharmacy fulfillment. It also provides clinical support and digital patient engagement tools. CaryHealth combines licensed pharmacy services with digital and AI tools to support patient access, medication adherence, clinical engagement and data-backed care across patients, providers and health plans. The partners will leverage HealthDyne's pharmacy infrastructure to facilitate the journey from prescription to patient and CaryHealth's direct-to-patient platform to help support ongoing therapy, medication adherence and program management. "We place a strong emphasis on the patient experience and the infrastructure required to support modern therapy access," Steve Saft, CEO of HealthDyne, said in a statement. "Together with CaryHealth, we're helping life sciences partners deliver direct-to-patient programs that remove barriers to treatments and make it easier for patients to start and stay on therapy."
Hype and headwinds alike at HLTH 2025. Nov 3rd, 2025 HLTH is always a high point on the calendar, and this year's event in Las Vegas was no exception. For the Definitive Healthcare team, it was a chance to meet face-to-face with customers and partners, share how Definitive Healthcare Corp. is helping organizations use data to see the market from any angle, and explore how real-world intelligence can uncover high-value opportunities and drive smarter growth heading into 2026. But if previous HLTH events felt like a pure celebration of innovation, this year's tone was a bit more grounded. Yes, the energy was still high, especially around the latest AI innovations and cutting-edge technologies, but there was also a noticeable undercurrent of concern. From mainstage keynotes to panel discussions, attendees grappled with tough challenges around the rising cost of care, millions losing Medicaid coverage, and the ongoing government shutdown, among other concerns that were top of mind. Still, HLTH 2025 was a showcase of bold ideas and forward momentum, even in the face of real headwinds. Couldn't make it to Vegas this year? No problem, below are some of the biggest takeaways and impressions its team brought back from the show floor. AI is still the headliner, and the hype isn't slowing down. Let's get the obvious out of the way: AI dominated the conversation at HLTH 2025, just as it has at nearly every major healthcare conference this year. But this wasn't just more buzz - it was clear that AI is shifting from potential to practical use across nearly every corner of the industry. AI agents lead the way. Healthcare organizations are embracing AI tools at scale, and a veritable avalanche of new AI agents was announced at the event. Across the show floor, companies unveiled new tools built to address very specific operational or clinical pain points. A few standouts: * Arbital Health's Merlin AI is a value-based care assistant that helps healthcare organizations cut through the fog of actuarial models. It aims to provide practical guidance by explaining performance drivers in plain language and recommending next best actions. * Ellipsis Health, in collaboration with NVIDIA, is expanding the emotional intelligence of its AI care manager, Sage, to better engage patients and extend staffing capacity through proactive check-ins and support. * GE HealthCare, Duke Health, and The Queen's Health Systems are teaming up to develop an AI-driven hospital operations platform focused on improving patient flow, resource utilization, and overall care quality. * Vital announced its new AI platform, Vital Urgent Care, that provides patients with real-time updates, wait times, and personalized guidance in urgent care settings. The diversity of these agents points to a few clear trends. Namely, collaboration is king. Many of these solutions are coming to life through partnerships: Health systems, tech companies, and AI developers combining forces to build faster and smarter. AI is also being embedded at every layer of care delivery. From patient-facing tools that streamline urgent care visits, to backend platforms that optimize hospital operations, the use cases for AI are rapidly expanding. Finally, transparency is a top priority among some of the AI innovations coming to the market. If AI is going to guide decisions in high-stakes environments, it needs to earn trust. That starts with making its reasoning visible and its outputs accountable. Can AI lighten the load? While it's exciting to see AI break into new markets, where it remains most impactful is in the trenches of healthcare, like billing and documentation, and daily workflows where inefficiencies stack up and burnout runs high. In revenue cycle management, billing, and coding, AI is streamlining some of healthcare's most time-consuming tasks, helping teams reduce errors, recover revenue faster, and free up staff for higher-value work. On the front end, tools are automating patient eligibility checks, generating real-time estimates, and reducing data entry errors at registration. In the middle of the cycle, natural language processing (NLP) is powering smarter coding suggestions, while machine learning models flag claims likely to be denied - before they're even submitted. On the back end, robotic process automation (RPA) is accelerating remittance posting, payor follow-ups, and reconciliation. Ambient documentation also stood out as an area where AI can step in to alleviate the administrative burdens physicians must manage daily. These tools, which record conversations between patients and clinicians and then generate clinical notes, have been around for a while, but were clunky, slow, inorganic, and sometimes inaccurate. AI and natural language processing are making the process faster and more accurate, enabling more face-to-face conversations while AI quietly handles the notetaking in the background. And of course, AI continues to gain traction in more advanced, data-intensive domains. As Definitive Healthcare Corp. has covered in the past, it's helping radiologists detect anomalies earlier and with greater precision and driving breakthroughs in pharmaceutical manufacturing from drug discovery to side effect prediction to supply chain optimization. The cost of care is a major concern. Entrepreneur Mark Cuban headlined HLTH this year and kicked off the event with a powerful discussion on the rising cost of care and prescription drugs. As the owner of Cost Plus Drugs, a company that sells low-cost prescriptions online, Cuban put a spotlight on systemic inefficiencies and pharmacy benefit managers for inflated drug prices that keep care unaffordable for millions of Americans. His message wasn't an outlier. Healthcare executives made it known at various panel discussions that they understand that too many people aren't pursuing care because of high prices while others resort to going into debt simply to get the care they need. As Definitive Healthcare Corp. outlined in its 2026 healthcare trends eBook, there are several forces contributing to high healthcare costs: * An aging U.S. population is increasing demand for care across specialties and settings * Chronic disease rates continue to climb, requiring long-term, resource-intensive management * The GLP-1 boom is reshaping pharmaceutical spending, with employers bracing for a projected 10% increase in healthcare costs in 2026 The challenge is that this trend is already impacting budgets in organizations across the industry and influencing how patients access care and the benefits the insured receive. Cuban acknowledged how complex the issue is and that it won't be solved overnight. Still, it is a positive sign that the high cost of care held significant space at HLTH. Providers, payors, life sciences companies, and tech companies will have to work together to find a solution that works. Policy instability is creating real anxiety across the industry. It's easy to focus on what's new and exciting at HLTH. But this year, the ongoing government shutdown and looming shifts in healthcare policy were top of mind for some leaders who shared their anxieties during the conference. * Medicare waivers supporting telehealth services at certain providers expired October 1, disrupting patients' access to care due to a lapse in renewing the federal spending bill. * Similarly, the Hospital-at-Home waiver has yet to be reinstated, pushing the financial risk onto hospitals by making it no longer possible to bill Medicare or Medicaid for acute care services rendered at home. * The tax credits that help millions afford insurance coverage under the Affordable Care Act are set to expire at the end of 2025 - and if they lapse, it's projected that millions could lose access to affordable care. * Over the next decade, an estimated 10 million people are expected to lose Medicaid coverage due to massive healthcare cuts introduced in the One Big Beautiful Bill Act. Still, even amid this uncertainty, the conversations at HLTH showed that healthcare leaders aren't standing still. Many are already thinking ahead, exploring alternative care models, pushing for regulatory clarity, and finding ways to adapt through innovation and collaboration. If anything, the turbulence is reinforcing how critical it is to build systems that are flexible, patient-centered, and grounded in data. Good data builds momentum. HLTH 2025 reminded Definitive Healthcare Corp. that the future of healthcare will belong to the organizations that can see clearly, move strategically, and act with confidence. To power big, innovative ideas or bring cutting-edge technologies or therapies to market, leaders need clear, comprehensive data. It's critical to making smarter decisions faster, and that's exactly what Definitive Healthcare solutions are built to provide. For providers, tech innovators, and businesses across the healthcare ecosystem, its data products and solutions make it easier to see the market from every angle, know where demand is growing, identify who's ready to buy and where care gaps exist, and figure out how your solution fits in. Book a demo with Definitive Healthcare today to see how its data can make a difference in your organization. Ethan popowitz is a senior content writer at Definitive Healthcare. He writes data-driven articles about telehealth, AI, the healthcare staffing shortage, and everything in...
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$85.1M
Headquarters
San Francisco, California
Founded
2017
Find jobs on Simplify and start your career today